The Medication Appropriateness Index at 20: Where It Started, Where It Has Been, and Where It May Be Going
- 771 Downloads
Potentially inappropriate prescribing for older adults is a major public health concern. While there are multiple measures of potentially inappropriate prescribing, the medication appropriateness index (MAI) is one of the most common implicit approaches published in the scientific literature. The objective of this narrative review is to describe findings regarding the MAI’s reliability, comparison of the MAI with other quality measures of potentially inappropriate prescribing, its predictive validity with important health outcomes, and its responsiveness to change within the framework of randomized controlled trials. A search restricted to English-language literature involving humans aged 65+ years from January 1992 to June 2013 was conducted using MEDLINE and EMBASE databases using the search term ‘medication appropriateness index’. A manual search of the reference lists from identified articles and the authors’ article files, book chapters, and recent reviews was conducted to identify additional articles. A total of 26 articles were identified for inclusion in this narrative review. The main findings were that the MAI has acceptable inter- and intra-rater reliability, it more frequently detects potentially inappropriate prescribing than a commonly used set of explicit criteria, it predicts adverse health outcomes, and it is able to demonstrate the positive impact of interventions to improve this public health problem. We conclude that the MAI may serve as a valuable tool for measuring potentially inappropriate prescribing in older adults.
KeywordsNarrative Review Inappropriate Prescribe Explicit Criterion Nursing Home Patient Beers Criterion
Supported in part by the National Institute on Aging Grants (R01-AG 027017, P30-AG024827, K07-AG033174, P30-AG028716), and an Agency for Healthcare Research and Quality Grant (R01-HS018721). The authors report no potential conflicts of interest.
- 9.Hanlon JT, Schmader K, Lewis I. Adverse drug reactions. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 2nd ed. Cincinnati: Harvey Whitney Books; 1995. p. 212–27.Google Scholar
- 28.Gillespie UM, Alassaad A, Hammarlund-Udenaes M, Mörlin C, Henrohn D, Bertilsson M, et al. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’ (MAI, STOPP and STARTs’) ability to predict hospitalization: analyses from a randomized controlled trial. Plos One. 2013;8:e62401.CrossRefPubMedGoogle Scholar
- 30.Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2:257–64.CrossRefPubMedGoogle Scholar
- 41.Volume CI, Burback LM, Farris KB. Reassessing the MAI: elderly persons opinions about medication appropriateness. Int J Pharm Pract. 1997;3:129–37.Google Scholar